NO20060950L - Fremgangsmate for a kontrollere krystallstrukturen i risedronat - Google Patents

Fremgangsmate for a kontrollere krystallstrukturen i risedronat

Info

Publication number
NO20060950L
NO20060950L NO20060950A NO20060950A NO20060950L NO 20060950 L NO20060950 L NO 20060950L NO 20060950 A NO20060950 A NO 20060950A NO 20060950 A NO20060950 A NO 20060950A NO 20060950 L NO20060950 L NO 20060950L
Authority
NO
Norway
Prior art keywords
risedronate
controlling
procedure
crystal structure
hydrate
Prior art date
Application number
NO20060950A
Other languages
English (en)
Other versions
NO335393B1 (no
Inventor
Jane Ellen Godlewski
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20060950L publication Critical patent/NO20060950L/no
Publication of NO335393B1 publication Critical patent/NO335393B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Seasonings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Pens And Brushes (AREA)

Abstract

Den foreliggende oppfirmelse vedrører en fremgangsmåte for å kontrollere krystallformen av 3-pyridyl- 1-hydroksyetyIlden-1,1-bisfosfonsyresalt (risedronat). Fremgangsmåten bruker et pH-justeringstrirm for å indusere den passende hydratformen og derved urmgå uheldig nukleering av uønskede hydratformer.
NO20060950A 2003-07-30 2006-02-27 Fremgangsmåte for fremstilling av 3-pyridyl-1-hydroksyetyliden-1,1-bisfosfonsyresalt i hemipentahydratkrystallform NO335393B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49122203P 2003-07-30 2003-07-30
PCT/US2004/022703 WO2005012314A1 (en) 2003-07-30 2004-07-15 Process for controlling crystal structure of risedronate

Publications (2)

Publication Number Publication Date
NO20060950L true NO20060950L (no) 2006-02-27
NO335393B1 NO335393B1 (no) 2014-12-08

Family

ID=34115482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060950A NO335393B1 (no) 2003-07-30 2006-02-27 Fremgangsmåte for fremstilling av 3-pyridyl-1-hydroksyetyliden-1,1-bisfosfonsyresalt i hemipentahydratkrystallform

Country Status (20)

Country Link
US (1) US7002014B2 (no)
EP (1) EP1651656B1 (no)
JP (1) JP4423614B2 (no)
KR (1) KR100786044B1 (no)
CN (1) CN100439377C (no)
AT (1) ATE493423T1 (no)
AU (1) AU2004261561B9 (no)
BR (1) BRPI0413067A (no)
CA (1) CA2529470C (no)
CO (1) CO5660304A2 (no)
DE (1) DE602004030801D1 (no)
IL (1) IL172676A (no)
IS (1) IS2915B (no)
MA (1) MA27914A1 (no)
MX (1) MXPA06001129A (no)
NO (1) NO335393B1 (no)
NZ (1) NZ544030A (no)
RU (1) RU2319706C2 (no)
SG (1) SG144151A1 (no)
WO (1) WO2005012314A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
JP5052816B2 (ja) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア ３−ピリジル−１−ヒドロキシエチリデン−１、１−ビスホスホン酸ナトリウム塩２．５水和物ａ型結晶の製造方法
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
MX2008014248A (es) 2006-05-11 2009-02-23 Ind Swift Lab Ltd Proceso para la preparacion de sales y acido risedronico puros.
WO2008044245A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of risedronate sodium hemipentahydrate
KR100828705B1 (ko) * 2006-12-04 2008-05-09 씨제이제일제당 (주) 리세드론산 나트륨 수화물의 제조방법
KR100775440B1 (ko) 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
KR100798855B1 (ko) * 2007-02-14 2008-01-28 주식회사 엔지켐 리세드론산 나트륨 헤미펜타하이드레이트의 제조방법
KR100812528B1 (ko) * 2007-04-12 2008-03-12 보령제약 주식회사 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
WO2009034580A1 (en) * 2007-09-11 2009-03-19 Fleming Laboratories Limited Improved process for the preparation of risedronate sodium hemipentahydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE69231313T2 (de) 1991-11-22 2001-03-15 Procter & Gamble Pharmaceuticals, Inc. Risedronat enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato

Also Published As

Publication number Publication date
CN100439377C (zh) 2008-12-03
NO335393B1 (no) 2014-12-08
DE602004030801D1 (de) 2011-02-10
SG144151A1 (en) 2008-07-29
IS8262A (is) 2006-01-25
EP1651656A1 (en) 2006-05-03
KR20060054297A (ko) 2006-05-22
KR100786044B1 (ko) 2007-12-17
IS2915B (is) 2014-12-15
AU2004261561B2 (en) 2008-06-26
US20050026869A1 (en) 2005-02-03
IL172676A (en) 2010-12-30
ATE493423T1 (de) 2011-01-15
WO2005012314A1 (en) 2005-02-10
CA2529470A1 (en) 2005-02-10
CO5660304A2 (es) 2006-07-31
JP2007500189A (ja) 2007-01-11
MA27914A1 (fr) 2006-05-02
CA2529470C (en) 2010-11-23
EP1651656B1 (en) 2010-12-29
CN1823078A (zh) 2006-08-23
NZ544030A (en) 2008-05-30
RU2319706C2 (ru) 2008-03-20
MXPA06001129A (es) 2006-04-11
RU2006102357A (ru) 2006-07-27
BRPI0413067A (pt) 2006-10-17
IL172676A0 (en) 2006-04-10
US7002014B2 (en) 2006-02-21
JP4423614B2 (ja) 2010-03-03
AU2004261561B9 (en) 2008-10-30
AU2004261561A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
NO20060950L (no) Fremgangsmate for a kontrollere krystallstrukturen i risedronat
ATE478082T1 (de) Phosphonate, monophosphonamidate, bisphosphonamidate zur behandlung von virenerkrankungen
HUP0204203A2 (en) Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
ATE497769T1 (de) Verfahren zur herstellung von ibandronat
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
EA200900779A1 (ru) Производные дигидропиридина, полезные как ингибиторы протеинкиназы
WO2003106416A3 (en) CHEMICAL PROCESS
CL2007001286A1 (es) Procedimiento para preparar amidas aromaticas del acido crotonico por formacion delcloruro de acido correspondiente y amidacion posterior.
IL172513A0 (en) Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
NO20065178L (no) Tienopyridinderivater
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
ATE405549T1 (de) Zur behandlung von entzündungen geeignete indole
SV2005002209A (es) Proceso
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
EA200701852A1 (ru) Производные аминокислот
ATE372114T1 (de) Verfahren zur erhöhung des testosteronspiegels
ZA200800138B (en) Process for the preparation of crystalline perindopril
JO2724B1 (en) 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors
MXNL04000051A (es) Proceso para la produccion de un inmunosupresor.
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
WO2006081543A3 (en) Crystalline phosphatase and method for use thereof
ATE414694T1 (de) Neue heterocyclylethylbenzamid-derivate